Response by Gargiulo et al to Letter Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial"

Giuseppe Gargiulo¹, Michael Nagler¹, Marco Valgimigli^{2

3}

Affiliations

¹ Department of Advanced Biomedical Sciences, Federico II University of Naples, Italy (G.G.).
² University of Bern, Switzerland (M.V.).
³ Cardiocentro Ticino, Lugano (M.V.).

Comment

Giuseppe Gargiulo et al. Circulation. 2021.

. 2021 Mar 30;143(13):e797-e798.

doi: 10.1161/CIRCULATIONAHA.120.051945. Epub 2021 Mar 29.

Giuseppe Gargiulo¹, Michael Nagler¹, Marco Valgimigli^{2

3}

¹ Department of Advanced Biomedical Sciences, Federico II University of Naples, Italy (G.G.).
² University of Bern, Switzerland (M.V.).
³ Cardiocentro Ticino, Lugano (M.V.).

No abstract available

Comment on

Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
Gargiulo G, Esposito G, Avvedimento M, Nagler M, Minuz P, Campo G, Gragnano F, Manavifar N, Piccolo R, Tebaldi M, Cirillo P, Hunziker L, Vranckx P, Leonardi S, Heg D, Windecker S, Valgimigli M. Gargiulo G, et al. Circulation. 2020 Aug 4;142(5):441-454. doi: 10.1161/CIRCULATIONAHA.120.046928. Epub 2020 Jun 27. Circulation. 2020. PMID: 32795098 Free PMC article. Clinical Trial.
Letter by Angiolillo et al Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial".
Angiolillo DJ, Bhatt DL, Stone GW. Angiolillo DJ, et al. Circulation. 2021 Mar 30;143(13):e795-e796. doi: 10.1161/CIRCULATIONAHA.120.050205. Epub 2021 Mar 29. Circulation. 2021. PMID: 33779271 No abstract available.